SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Amanta Healthcare Ltd (AMANTA)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 544502 NSE: AMANTA Pharmaceuticals & Drugs | Small Cap | Amanta Healthcare Share Price

₹133.30 12.55 (10.39%)

As on 04-Jun'26 16:59

Amanta Healthcare Ltd (AMANTA)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 544502 NSE: AMANTA Pharmaceuticals & Drugs | Small Cap | Amanta Healthcare Share Price

₹133.30 12.55 (10.39%)

As on 04-Jun'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹518 Cr.
Current Price
₹133.3
52-Week Low / High
₹93 / 155
TTM EPS
₹3.8
TTM Sales
₹288 Cr.
Book Value per Share
₹56.7
P/E Ratio
34.80
Industry PE
46.5
Price to Book (P/B)
2.35
Price to Sales (P/S)
1.80
EV/EBITDA
10.43
Dividend Yield
0.00%
Profitability Efficiency
Return on Equity (ROE)
12.91%
Return on Capital Employed (ROCE)
15.16%
Return on Assets (ROA)
2.82%
Operating Profit Margin
21.8%
Net Profit Margin
3.82%
Gross Profit Margin
12.1%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
-2.01%
Operating Profit Growth (1 Year)
Improving versus 3-year growth rate
3.79%
Net Profit Growth (1 Year)
Improving versus 3-year growth rate
189.26%
Asset Quality
Promoter Holding
63.72%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹181 Cr.
Equity
₹38.8 Cr.
Face Value
₹10
All Time Low / High
₹93.10 / 154.85

Amanta Healthcare stock performance

Key Ratios
mw4me loader

Check Before You Invest

Quality

Somewhat Good

Valuation

Somewhat Overvalued

Price Trend

Strong
Q.1 Is Amanta Healthcare Ltd a good quality company?
Amanta Healthcare Ltd is a average quality company, based on a somewhat consistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does Amanta Healthcare Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Amanta Healthcare Ltd vs industry peers?
Amanta Healthcare Ltd revenue CAGR is 8.30%, compared to the industry median CAGR of 5.35%, indicating faster growth and gaining its market share.
Q.1 Promoter shareholding and pledge status of Amanta Healthcare Ltd?
Promoters hold 63.72% of the Amanta Healthcare Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Amanta Healthcare Ltd over the last decade?
Over the last - year(s), the stock has delivered a CAGR of N/A% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Amanta Healthcare Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 10.6%12.7%10.3%8.4%8.3%8.9%40%13.4%14.2%15.2%-
Value Creation
Index
-0.2-0.1-0.3-0.4-0.4-0.41.90.00.00.1-

Growth Parameters

Sales 203211192185184171225259280275288
Sales YoY Gr.-4.2%-9.3%-3.5%-0.3%-7.1%31.6%14.9%8.2%-2%-
Adj EPS 3.46.33.9-7.1-7.5-8.22.1-1.21.53.63.8
YoY Gr.-88.1%-38.6%-282.5%NANANA-156.6%NA143%-
BVPS (₹) 4046.32517.910.92.724.223.424.733.456.7
Adj Net
Profit
12.423.210.3-19-20-22.15.7-3.2410.415
Cash Flow from Ops. 39.640.225.232.237.933.463.542.658.146.6-
Debt/CF from Ops. 2.42.210.17.76.173.55.13.54.2-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales 3.4%8.3%6.8%-2%
Adj EPS 0.8%NA19.5%143%
BVPS-2%25.2%11.3%35.3%
Share Price - - - -

Key Financial Parameters

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
6.911.47.3-33.1-52-121.415.7-5.16.212.88.5
Op. Profit
Mgn %
20.424.424.222.120.322.423.819.820.721.820.8
Net Profit
Mgn %
6.1115.4-10.3-10.9-12.92.5-1.31.43.85.2
Debt to
Equity
0.50.43.85.27.932.33.43.43.120.7
Working Cap
Days
180194238269277296215179162181147
Cash Conv.
Cycle
6559911141331601201039711168

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales203211192185184171225259280275
Operating Expenses + 161160145144147133172208223215
Manufacturing Costs21202121231973838483
Material Costs85826867645040617057
Employee Cost 28283031333428323336
Other Costs 28312525263031323638
Operating Profit 41514641373854515760
Operating Profit Margin (%) 20.4%24.3%24.2%22.1%20.3%22.4%23.8%19.6%20.5%21.7%
Other Income + 2122211511
Exceptional Items 0-0000069000
Interest 14122041384044353428
Depreciation 14151617161717182018
Profit Before Tax 152512-14-15-18623515
Tax 3214448524
Profit After Tax 132311-19-19-2254-2411
PAT Margin (%) 6.2%11.0%5.9%-10.1%-10.2%-12.8%23.9%-0.8%1.3%3.8%
Adjusted EPS (₹)3.46.34.3-7.0-7.0-8.120.1-0.81.43.6
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Valuation of Amanta Healthcare - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 192215674829765636696
Share Capital 82822727272727272729
Reserves 11013440212-2038363968
Debt +8676243238227235218211192173
Long Term Debt4232200196192158176176149132
Short Term Debt44434342347742364341
Minority Interest0000000000
Trade Payables32352922172539362530
Others Liabilities 5864679511512558647288
Total Liabilities 369390406403388392379374355389

Fixed Assets

Net Fixed Assets +246262267247244242241238228217
Gross Block347375396383395399259274279286
Accumulated Depreciation10111312913615215718365168
CWIP 0120000007
Investments 0000023348
Inventories30293438395771695973
Trade Receivables52615452525145544850
Cash Equivalents 657136910443
Others Assets 353242524631971231
Total Assets 369390406403388392379374355389

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity + 40402532383364435847
PBT 152512-14-15-18623515
Adjustment 282736565459-7545447
Changes in Working Capital -0-7-17-3-1-139-75-11
Tax Paid -3-3-2-7-05-0-6-6-4
Cash Flow From Investing Activity + -36-21-175-5-11-17-5-7-10-24
Capex -37-23-15-5-11-12-3-6-12-21
Net Investments 000000-3-01-4
Others 12-160-0-0-50000
Cash Flow From Financing Activity + -3-20152-21-35-17-52-42-46-23
Net Proceeds from Shares 10000000020
Net Proceeds from Borrowing 0000000000
Interest Paid -15-12-12-15-19-21-41-29-26-25
Dividend Paid 0000000000
Others 11-7164-6-164-11-13-20-18
Net Cash Flow 0-026-8-06-61-1

Financial Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)9.3314.599.57-32.75-48.98-120.09149.18-3.35.6312.91
ROCE (%)10.6312.6910.338.448.278.9139.9913.4314.1915.16
Asset Turnover Ratio0.610.590.490.460.470.440.580.690.770.74
PAT to CFO Conversion(x)3.081.742.27N/AN/AN/A1.19N/A14.54.27
Working Capital Days
Receivable Days78.9091.60108.40105103.50110.607869.3066.2065.30
Inventory Days5748.2059.2071.3076.90102.90103.9098.6083.6088
Payable Days132.40150.30170.70139.80112.40157.30290.80223.30158.80175.60

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Amanta Healthcare Ltd FAQs

The current trading price of Amanta Healthcare on 04-Jun-2026 16:59 is ₹133.3.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Jun-2026 the market cap of Amanta Healthcare stood at ₹517.6 Cr

The latest P/E ratio of Amanta Healthcare as of 03-Jun-2026 is 34.80.

The latest P/B ratio of Amanta Healthcare as of 03-Jun-2026 is 2.35.

The 52-week high of Amanta Healthcare is ₹154.8 and the 52-week low is ₹93.10.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Amanta Healthcare is ₹288 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Amanta Healthcare Ltd is a average quality company.

The key valuation ratios of Amanta Healthcare Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Amanta Healthcare Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

About Amanta Healthcare Ltd

Marck Biosciences Limited was originally incorporated as Marck Parenterals (India) Limited on December 1994. Subsequently, the name of the company was changed to Marck Biosciences Limited on November 2, 2005. The company’s registered office is located at 5th Floor, Heritage, Nr. Gujarat Vidhyapith, Off. Ashram Road,Ahmedabad – 380 014, Gujarat, India. It manufacture and market around 80 therapeutic and non therapeutic products. Its therapeutic product groups comprise of Fluid Therapy, Injections, Eye Care and Respiratory Care. Its non therapeutic product group comprises of Medical Devices. Medical devices would predominantly be of products such as, Lens cleaning solutions, Eye & wound Irrigation, Eye wash Solution and First aid Solution, for which the company has obtained ‘CE’ mark.

Business Profile:

The company is a sterile liquid pharmaceutical company headquartered at Ahmedabad, Gujarat, India. Its scope of activities includes formulation and development, manufacturing and marketing in India and approximately 77 countries across 6 continents. It manufacture and market around 80 therapeutic and non therapeutic products. Its therapeutic product groups comprise of fluid therapy, injections, eye care and respiratory care. The non therapeutic product group comprises of medical devices. medical devices would predominantly be of products such as, lens cleaning solutions, eye and wound irrigation, eye wash solution and first aid Solution, for which the company has obtained ‘CE’ mark. Its manufacturing facilities comprises of five Aseptic Blow Fill Seal (ABFS) manufacturing lines and one Aspectic Conventional Plastic Bottle Filling line. It is one of the versatile manufacturer in BFS space, wherein it offer different closure systems, such as nipple head, twist-off, leur-lock & screw types and container fill-volume ranging from 2ml to 1000 ml.

Product Segment:

  • Fluid Therapy Products
  • Formulations
  • Medical Devices

Promoter Group Companies :

  • Milcent Appliances Private Limited (MAPL)
  • American Mannequin INC

Group entities:

  • Marck Remedies Limited (MRL)
  • Mangneto Induction Pvt Limited
You have 0 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×